Nevro Net Worth 2013-2022 | NVRO

Interactive chart of historical net worth (market cap) for Nevro (NVRO) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Nevro net worth as of December 07, 2022 is $1.48B.
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.482B $0.387B
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $218.900B 22.89
Edwards Lifesciences (EW) United States $44.873B 30.89
Alcon (ALC) Switzerland $33.262B 28.64
STERIS (STE) Ireland $18.523B 23.05
Teleflex (TFX) United States $11.273B 18.29
Fresenius Medical Care AG KGaA (FMS) Germany $9.266B 9.30
Penumbra (PEN) United States $8.355B 2000.00
Globus Medical (GMED) United States $6.995B 35.56
Integer Holdings (ITGR) United States $2.380B 19.11
Glaukos (GKOS) United States $2.160B 0.00
Paragon 28 (FNA) United States $1.535B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.208B 17.20
Artivion (AORT) United States $0.511B 0.00